XML 23 R8.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Jan. 02, 2016
Jan. 03, 2015
Operating Activities      
Net Income Attributable to Kadant $ 32,077 $ 34,389 $ 28,659
Net income attributable to noncontrolling interest 392 294 389
(Income) loss from discontinued operation (3) (74) 23
Income from continuing operations 32,466 34,609 29,071
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:      
Depreciation and amortization 14,326 10,821 11,189
Stock-based compensation expense 5,069 5,741 5,813
Tax benefits from stock-based compensation awards 0 (881) (771)
Provision for losses on accounts receivable 453 379 246
(Gain) loss on sale of property, plant, and equipment (350) 4 (118)
Deferred income tax (benefit) provision (613) (1,706) 2,951
Other items, net 1,362 (287) 1,318
Contributions to U.S. pension plan (1,080) (1,080) (1,080)
Changes in current assets and liabilities, net of effects of acquisitions:      
Accounts receivable 1,003 (10,640) 8,429
Unbilled contract costs and fees 3,407 (1,534) (2,277)
Inventories 3,553 (6,486) 5,067
Other current assets 753 1,495 (563)
Accounts payable (5,238) (1,752) 652
Other current liabilities (4,111) 11,727 (8,817)
Net cash provided by continuing operations 51,000 40,410 51,110
Net cash provided by (used in) discontinued operation 3 (38) 5
Net cash provided by operating activities 51,003 40,372 51,115
Investing Activities      
Acquisitions, net of cash acquired (Note 2) (56,617) 0 (11,984)
Purchases of property, plant, and equipment (5,804) (5,479) (6,755)
Proceeds from sale of property, plant, and equipment 428 30 242
Net cash used in continuing operations for investing activities (61,993) (5,449) (18,497)
Financing Activities      
Proceeds from issuance of short- and long-term obligations 51,046 24,000 24,512
Repayments of short- and long-term obligations (18,429) (18,611) (36,953)
Purchases of Company common stock 0 (9,906) (15,136)
Dividends paid (8,038) (7,179) (6,339)
Tax withholding payments related to stock-based compensation (2,572) (2,499) (2,243)
Proceeds from issuance of Company common stock 2,350 754 1,119
Payment of contingent consideration (Note 2) (1,091) 0 0
Change in restricted cash (789) (1,066) (299)
Tax benefits from stock-based compensation awards 0 881 771
Other items 189 0 0
Net cash provided by (used in) continuing operations for financing activities 22,666 (13,626) (34,568)
Exchange Rate Effect on Cash and Cash Equivalents from Continuing Operations (5,714) (1,145) (2,704)
Change in Cash from Discontinued Operation (5) 0 0
Increase (Decrease) in Cash and Cash Equivalents from Continuing Operations 5,957 20,152 (4,654)
Cash and Cash Equivalents at Beginning of Year 65,530 45,378 50,032
Cash and Cash Equivalents at End of Year $ 71,487 $ 65,530 $ 45,378